Antiinflammatory and Immunosuppressive Functions of Mast Cells

Methods in Molecular Biology

Volumn 677, Issue , 2011, Pages 207-220

  Kalesnikoff, Janet ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMCMCs; BMMCs; Engraftment; IL 10; Mast cell deficient mice

Indexed keywords

ANTIINFLAMMATORY AGENT; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10;

ANIMAL; ARTICLE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MAST CELL; MOUSE; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE MARROW CELLS; CELLS, CULTURED; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-10; MAST CELLS; MICE; MICE, INBRED C57BL;

EID: 79952202461     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-869-0_15     Document Type: Chapter

References (28)

1. Metz M, Grimbaldeston MA, Nakae S, et al. (2007) Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 217, 304–28.
2. Galli SJ, Grimbaldeston M, Tsai M. (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8, 478–86.
3. Kalesnikoff J, Galli SJ. (2008) New developments in mast cell biology. Nat Immunol 9, 1215–23.
4. Galli SJ, Kalesnikoff J, Grimbaldeston MA, et al. (2005) Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23, 749–86.
5. Scholten J, Hartmann K, Gerbaulet A, et al. (2008) Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res 17, 307–15.
6. Musch W, Wege AK, Mannel DN, et al. (2008) Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis 46, 163–6.
7. Hart PH, Grimbaldeston MA, Swift GJ, et al. (1998) Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187, 2045–53.
8. Depinay N, Hacini F, Beghdadi W, et al. (2006) Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 176, 4141–6.
9. Lu LF, Lind EF, Gondek DC, et al. (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997–1002.
10. Grimbaldeston MA, Nakae S, Kalesnikoff J, et al. (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8, 1095–104.
11. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167, 835–48.
12. (W-sh) sash mice. Clin Exp Allergy 35, 82–8.
13. v mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162, 1025–43.
14. Echtenacher B, Mannel DN, Hultner L. (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75–7.
15. Jippo T, Morii E, Ito A, et al. (2003) Effect of anatomical distribution of mast cells on their defense function against bacterial infections: demonstration using partially mast cell-deficient tg/tg mice. J Exp Med 197, 1417–25.
16. W-sh/W-sh mice Am J Pathol 176, 926–38.
17. Tsai M, Miyamoto M, Tam SY, et al. (1995) Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. Am J Pathol 146, 335–43.
18. W-sh mice does not impair antibody-mediated arthritis. J Exp Med 204, 2797–802.
19. sh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol 173, 1693–701.
20. v mice that are genetically deficient in mast cells. J Exp Med 165, 615–27.
21. Tanzola MB, Robbie-Ryan M, Gutekunst CA, et al. (2003) Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 171, 4385–91.
22. Metz M, Piliponsky AM, Chen CC, et al. (2006) Mast cells can enhance resistance to snake and honeybee venoms. Science 313, 526–30.
23. Piliponsky AM, Chen CC, Nishimura T, et al. (2008) Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med 14, 392–8.
24. Martin TR, Takeishi T, Katz HR, et al. (1993) Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 91, 1176–82.
25. Williams CM, Galli SJ. (2000) Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192, 455–62.
26. Yu M, Tsai M, Tam SY, et al. (2006) Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116, 1633–41.
27. Nakae S, Ho LH, Yu M, et al. (2007) Mast cell-derived TNF contributes to airway hyper-reactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J Allergy Clin Immunol 120, 48–55.
28. Wershil BK, Murakami T, Galli SJ. (1988) Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol 140, 2356–60.